Bank of America Corporation »

Nervgen Pharma Ord shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGENF) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $757k 201k 3.77

More positions owned by Bank of America Corporation

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Bank of America Corporation

Top funds holding Nervgen Pharma Ord

PFG Investments
Bank of America Corporation
Marshall Wace
Royal Bank of Canada
Integrated Wealth Concepts
Valley Forge Investment Consultants Inc Adv
Bank Of Montreal
Captrust Financial Advisors
UBS Group
Advisor Group Holdings
Patriot Financial Group Insurance Agency
Commonwealth Equity Services
Cetera Investment Advisers
McKinley Carter Wealth Services
Traynor Capital Management

View all funds holding Nervgen Pharma Ord